CD274 and neoplasm: However, existing biomarkers like PD-L1 expression, microsatellite instability (MSI), and Epstein–Barr virus (EBV) infection status, while partially predictive of therapeutic efficacy, exhibit high heterogeneity in expression influenced by tumor histotype, individual genetic background, and dynamic microenvironment changes (2).